CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,795 | -5.4% | 16,399 | 0.0% | 0.00% | – |
| Q2 2023 | $24,107 | -10.9% | 16,399 | 0.0% | 0.00% | – |
| Q1 2023 | $27,058 | +17.9% | 16,399 | 0.0% | 0.00% | – |
| Q4 2022 | $22,959 | -11.7% | 16,399 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | -29.7% | 16,399 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -85.5% | 16,399 | -84.1% | 0.00% | – |
| Q1 2022 | $256,000 | -56.5% | 103,143 | +5.5% | 0.00% | – |
| Q4 2021 | $588,000 | -9.8% | 97,763 | 0.0% | 0.00% | – |
| Q3 2021 | $652,000 | +14.4% | 97,763 | +14.2% | 0.00% | – |
| Q2 2021 | $570,000 | +243.4% | 85,617 | +635.8% | 0.00% | – |
| Q3 2020 | $166,000 | – | 11,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |